SMFR

Sema4 Holdings Corp. [SMFR] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SMFR Stock Summary

In the News

10:29 26 Sep 2023 SMFR

Sema4: Restructuring Plan Figures Don't Add Up

Sema4's restructuring plan has a number of potential downsides that could affect the company's cash position in the coming few quarters. The booting of the CEO signals the start of a strategic focus on short-term survival away from long-term growth.

10:46 26 Sep 2023 SMFR

Sema4 Holdings Corporation (SMFR) Q3 2022 Earnings Call Transcript

Sema4 Holdings Corporation (NASDAQ:SMFR ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Joel Kaufman - VP, Finance & Corporate Development Katherine Stueland - CEO & Director Kevin Feeley - SVP, Operations & CFO Conference Call Participants Mark Massaro - BTIG David Delahunt - Goldman Sachs Operator Welcome to the Sema4 Third Quarter 2022 Earnings Conference Call. My name is Cheryl, and I will be your operator for today's call.

11:32 26 Sep 2023 SMFR

Why Sema4 Holdings Stock Is Crashing Today

The healthcare company delivered plenty of bad news in its Q2 update.

09:29 26 Sep 2023 SMFR

Sema4 Holdings Corp (SMFR) CEO Katherine Stueland on Q2 2022 Results - Earnings Call Transcript

Sema4 Holdings Corp (NASDAQ:SMFR ) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Joel Kaufman - VP, Finance & Corporate Development Katherine Stueland - CEO & Director Kevin Feeley - SVP, Operations and Head of GeneDx Conference Call Participants David Delahunt - Goldman Sachs Group Matt Kim - Jeffrey Max Masucci - Cowen and Company Mark Massaro - BTIG Operator Good day, and thank you for standing by. Welcome to the Sema4 Second Quarter 2022 Earnings Conference Call.

12:02 26 Sep 2023 SMFR

Sema4 Holdings, Big Data For Precision Medicine Solutions

Big data and machine learning are booming also in healthcare, where it enables precision medicine and population health platform services. Sema4 Holdings has amassed huge amounts of medical data and a sophisticated platform in order to extract valuable insight from these for health systems, pharma companies and individuals.

01:27 26 Sep 2023 SMFR

Sema4 Holdings Corp. (SMFR) Moves to Buy: Rationale Behind the Upgrade

Sema4 Holdings Corp. (SMFR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

10:52 26 Sep 2023 SMFR

Sema4 Holdings Corp. (SMFR) CEO Katherine Stueland on Q1 2022 Results - Earnings Call Transcript

Sema4 Holdings Corp. (NASDAQ:SMFR ) Q1 2022 Earnings Conference Call May 13, 2022 4:30 PM ET Company Representatives Katherine Stueland - Chief Executive Officer Eric Schadt - Founder, President and Chief R&D Officer Isaac Ro - Chief Financial Officer Joel Kaufman - Vice President of Finance and Corporate Development Conference Call Participants Mark Massaro - BTIG Max Masucci - Cowen and Company Dave Delahunt - Goldman Sachs Operator Good day! And thank you for standing by.

07:57 26 Sep 2023 SMFR

Sema4 Holdings Corp. (SMFR) CEO Eric Schadt on Q4 2021 Results - Earnings Call Transcript

Sema4 Holdings Corp. (SMFR) CEO Eric Schadt on Q4 2021 Results - Earnings Call Transcript

09:39 26 Sep 2023 SMFR

Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition

Sema4 Holdings Corp (NASDAQ: SMFR) has agreed to acquire OPKO Health Inc's (NASDAQ: OPK) wholly-owned subsidiary, GeneDx Inc, for approximately $623 million. Sema4 will acquire GeneDx for an upfront payment of $150 million in cash plus 80 million shares in Sema4, with up to an additional $150 million revenue-based milestones over the next two years.

07:36 26 Sep 2023 SMFR

Sema4 Stock (SMFR): Why The Price Jumped

The stock price of Sema4 Holdings Corp (NASDAQ: SMFR) increased by 13.63% in the most recent trading session. This is why it happened.

SMFR Financial details

Company Rating
Neutral
Market Cap
246.37M
Income
-446.02M
Revenue
236.43M
Book val./share
1.47
Cash/share
0.5
Dividend
-
Dividend %
-
Employees
1.2K
Optionable
No
Shortable
Yes
Earnings
13 Mar 2023
P/E
-10.69
Forward P/E
-
PEG
-0
P/S
1.1
P/B
18.97
P/C
-
P/FCF
-0.83
Quick Ratio
1.97
Current Ratio
2.29
Debt / Equity
0.48
LT Debt / Equity
0.24
-
-
EPS (TTM)
-158.72K
EPS next Y
-
EPS next Q
-
EPS this Y
31664621.36%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
12.9%
EPS Q/Q
-41.94%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
2.17%
Inst Trans
3.06%
ROA
-107%
ROE
-131%
ROC
-1.38%
Gross Margin
-55%
Oper. Margin
-262%
Profit Margin
-260%
Payout
-
Shs Outstand
793.21M
Shs Float
241.9M
-
-
-
-
Target Price
2.33
52W Range
0.22-4.09
52W High
-
52W Low
-
RSI
-
Rel Volume
2.34
Avg Volume
2.01M
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

SMFR Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2020-12-31 2021-12-31
Revenue per share
00.88
Net income per share
0-1.02
Operating cash flow per share
0-0.79
Free cash flow per share
0-0.88
Cash per share
1.851.67
Book value per share
0.021.62
Tangible book value per share
1.781.62
Share holders equity per share
0.021.62
Interest debt per share
00.15
Market cap
2.65B1.07B
Enterprise value
2.65B703.53M
P/E ratio
-13.79K-4.37
Price to sales ratio
05.05
POCF ratio
0-5.63
PFCF ratio
0-5.07
P/B Ratio
530.342.76
PTB ratio
530.342.76
EV to sales
03.32
Enterprise value over EBITDA
-13.79K-3.19
EV to operating cash flow
0-3.69
EV to free cash flow
0-3.33
Earnings yield
0-0.23
Free cash flow yield
0-0.2
Debt to equity
3.120.43
Debt to assets
0.040.3
Net debt to EBITDA
5.691.67
Current ratio
14.124.77
Interest coverage
0-157.37
Income quality
00.78
Dividend Yield
00
Payout ratio
00
Sales general and administrative to revenue
00.97
Research and developement to revenue
00.5
Intangibles to total assets
00
Capex to operating cash flow
00.11
Capex to revenue
0-0.1
Capex to depreciation
0-0.95
Stock based compensation to revenue
01.03
Graham number
0.026.09
ROIC
-0.551.53
Return on tangible assets
0-0.44
Graham Net
1.781.13
Working capital
1.27M382.26M
Tangible asset value
428.54M388.1M
Net current asset value
-14.22M317.55M
Invested capital
00.08
Average receivables
013.28M
Average payables
022.35M
Average inventory
016.73M
Days sales outstanding
045.69
Days payables outstanding
071.3
Days of inventory on hand
053.37
Receivables turnover
07.99
Payables turnover
05.12
Inventory turnover
06.84
ROE
-0.04-0.63
Capex per share
0-0.09

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
00.240.220.150.22
Net income per share
0-0.17-0.32-0.76-0.2
Operating cash flow per share
-0.74-0.22-0.34-0.35-0.23
Free cash flow per share
-0.76-0.25-0.34-0.36-0.24
Cash per share
01.661.31.180.5
Book value per share
01.611.362.641.47
Tangible book value per share
01.611.361.090.5
Share holders equity per share
01.611.362.641.47
Interest debt per share
00.140.310.330.21
Market cap
1.41B1.08B741.38M304.28M334.12M
Enterprise value
1.41B709.33M499.93M98.19M220.74M
P/E ratio
0-6.66-2.41-0.41-1.08
Price to sales ratio
018.6313.748.414.01
POCF ratio
-10.25-20.72-9.1-3.59-3.78
PFCF ratio
-9.93-18.05-8.95-3.54-3.69
P/B Ratio
3.6K2.782.250.480.6
PTB ratio
3.6K2.782.250.480.6
EV to sales
012.279.272.712.65
Enterprise value over EBITDA
87.99-20.91-7.11-0.79-3.33
EV to operating cash flow
-10.24-13.64-6.13-1.16-2.5
EV to free cash flow
-9.93-11.89-6.03-1.14-2.44
Earnings yield
0-0.04-0.1-0.6-0.23
Free cash flow yield
-0.1-0.06-0.11-0.28-0.27
Debt to equity
0.540.430.570.460.48
Debt to assets
0.350.30.360.320.32
Net debt to EBITDA
-0.0310.843.441.651.71
Current ratio
7.554.774.081.971.89
Interest coverage
0-164.1-110.53-205.88-112.67
Income quality
01.291.060.991.14
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
010.791.880.62
Research and developement to revenue
00.380.40.750.16
Intangibles to total assets
0000.40.45
Capex to operating cash flow
0.030.150.020.020.03
Capex to revenue
0-0.13-0.03-0.04-0.03
Capex to depreciation
-0.27-1.33-0.24-0.15-0.21
Stock based compensation to revenue
00.640.330.630.02
Graham number
02.463.136.722.6
ROIC
00.40.49-0.89-0.25
Return on tangible assets
0-0.07-0.15-0.33-0.17
Graham Net
01.120.720.18-0.06
Working capital
467.15K382.26M309.79M198.1M144.28M
Tangible asset value
391.26K388.1M329.44M262.43M189.67M
Net current asset value
326.42K317.55M222.2M106.7M38.93M
Invested capital
0.030.080.220.120.14
Average receivables
12.51M13.29M32.1M41.72M44.24M
Average payables
21.83M22.35M56.79M92.38M101.38M
Average inventory
14.58M16.74M34.89M38.96M42.89M
Days sales outstanding
041.3662.81113.9746.14
Days payables outstanding
082.76128.31158.58112.21
Days of inventory on hand
061.9567.6556.9357.05
Receivables turnover
02.181.430.791.95
Payables turnover
01.090.70.570.8
Inventory turnover
01.451.331.581.58
ROE
0-0.1-0.23-0.29-0.14
Capex per share
-0.02-0.03-0.01-0.01-0.01

SMFR Frequently Asked Questions

What is Sema4 Holdings Corp. stock symbol ?

Sema4 Holdings Corp. is a US stock , located in Stamford of Ct and trading under the symbol SMFR

Is Sema4 Holdings Corp. buy or a sell ?

4 stock analysts have 4 predictions with a medium analyst target price of $2.63. The lowest prediction is $1 and the highest is $3.5

What is SMFR stock prediction ?

What is Sema4 Holdings Corp. stock quote today ?

Sema4 Holdings Corp. stock price is $- today.

Is Sema4 Holdings Corp. stock public?

Yes, Sema4 Holdings Corp. is a publicly traded company.

Something similar